Epigenetically altered circulating nucleosomes as blood biomarkers for early detection of cancer: clinical studies in NSCLC, CRC, PCA and PC

被引：0
|
作者：
Micallef, Jake V.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4476
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4476
引用
收藏
页数：4
相关论文
共 10 条
  • [1] Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer
    Rahier, Jean-Francois
    Druez, Anne
    Faugeras, Laurence
    Martinet, Jean-Paul
    Gehenot, Myriam
    Josseaux, Eleonore
    Herzog, Marielle
    Micallef, Jake
    George, Fabienne
    Delos, Monique
    De Ronde, Thierry
    Badaoui, Abdenor
    D'Hondt, Lionel
    CLINICAL EPIGENETICS, 2017, 9
  • [2] Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer
    Jean-François Rahier
    Anne Druez
    Laurence Faugeras
    Jean-Paul Martinet
    Myriam Géhénot
    Eléonore Josseaux
    Marielle Herzog
    Jake Micallef
    Fabienne George
    Monique Delos
    Thierry De Ronde
    Abdenor Badaoui
    Lionel D’Hondt
    Clinical Epigenetics, 2017, 9
  • [3] Circulating biomarkers for early detection and clinical management of colorectal cancer
    Marcuello, Maria
    Vymetalkova, Veronika
    Neves, Rui P. L.
    Duran-Sanchon, Saray
    Vedeld, Hege Marie
    Tham, Emma
    van Dalum, Guus
    Fluegen, Georg
    Garcia-Barberan, Vanesa
    Fijneman, Remond Ja.
    Castells, Antoni
    Vodicka, Pavel
    Lind, Guro E.
    Stoecklein, Nikolas H.
    Heitzer, Ellen
    Gironella, Meritxell
    MOLECULAR ASPECTS OF MEDICINE, 2019, 69 : 107 - 122
  • [4] Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments
    Qiu, Jie
    Qian, Da
    Jiang, Yuancong
    Meng, Liwei
    Huang, Liming
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] Integrative analysis of blood biomarkers and clinical variables improves early detection of aggressive prostate cancer
    Olga Lazareva
    Anja Riediger
    Oliver Stegle
    Holger Sültmann
    Markus Hohenfellner
    Magdalena Görtz
    Scientific Reports, 15 (1)
  • [6] The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
    Cree, Ian A.
    Uttley, Lesley
    Woods, Helen Buckley
    Kikuchi, Hugh
    Reiman, Anne
    Harnan, Susan
    Whiteman, Becky L.
    Philips, Sian Taylor
    Messenger, Michael
    Cox, Angela
    Teare, Dawn
    Sheils, Orla
    Shaw, Jacqui
    BMC CANCER, 2017, 17
  • [7] The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
    Ian A. Cree
    Lesley Uttley
    Helen Buckley Woods
    Hugh Kikuchi
    Anne Reiman
    Susan Harnan
    Becky L. Whiteman
    Sian Taylor Philips
    Michael Messenger
    Angela Cox
    Dawn Teare
    Orla Sheils
    Jacqui Shaw
    BMC Cancer, 17
  • [8] Real-world evaluation of clinical utility of ColonAiQ, a blood-based assay for colorectal cancer (CRC) early detection
    Ding, Y.
    Liu, J.
    Liu, R.
    Zhang, Y.
    Li, Y.
    Li, F.
    Wang, C.
    Jia, H.
    Pan, W.
    Yang, H.
    Luo, H.
    Li, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S377 - S377
  • [9] Clinical validation: A blood- based biomarker for early lung cancer detection based on circulating DNA fragmentomics
    Mazzone, Peter
    Bach, Peter B.
    Cotton, Lindsey B.
    Schonewolf, Caitlin A.
    CANCER RESEARCH, 2024, 84 (06)
  • [10] Evaluating cost-effectiveness and clinical utility of a blood-based colorectal cancer (CRC) early detection assay, ColonAiQ™, through a real-world study in average-risk population (PreC).
    Ding, Yanbing
    Liu, Jun
    Li, Yongsheng
    Wang, Cuiping
    Luo, Huisong
    Li, Yang
    Tang, Tingdong
    Wang, Hui
    Pan, Wenjun
    Yang, Huimin
    Jia, Haipeng
    Zhang, Yunzhi
    Liu, Rui
    CANCER RESEARCH, 2022, 82 (12)
1